UN backed group sub-licence drug
Pfizer has agreed to allow companies to make a generic version of its Covid treatment pill.
Data from the company says it reduces the risk of hospitalisation by 89 per cent.
The licensing agreement with the Medicines Patent Pool was announced today, and allows the UN backed group to issue sub-licences.
The drug will be administered alongside Ritanovir, which is widely used to treat HIV.

Reports Of Iran And Oman Working Towards Deal To Reopen Strait Of Hormuz
EU Home Affairs Ministers Meet To Discuss Protection Of Borders From Illegal Migration
Donald Trump Says "Board of Peace" Has Reached An Agreement For Disarment Of Hamas
Daniel Kinahan Set To Face Trial In Ireland
"All Of Europe" Could Be On Fire In Coming Days, Says EU Agency, As Two Firemen Die In Greece
Fuel At The Pump Could Reach €2.30/L If Middle East Conflict Continues
Google Hit With €890M Fine By European Commission
Andy Burnham Sworn In As British Labour Leader